Abstract

Faced with the task of submitting new drug applications and then waiting for the review process to end, a number of firms are participating in computer assisted new drug applications (CANDAs), the information technology exchange experiment between the Food and Drug Administration (FDA) and major pharmaceutical makers. The Merck Medical CANDA is an attempt to improve the situation by developing a PC-based, user-friendly system, under MS Windows 3.0, that facilitates quick access, review, assimilation, and presentation of clinical trial data, for the in-house medical and statistical review of the data, as well as for use at the FDA. >

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.